Cargando…

Antiplatelet Therapy with Integrated Traditional Chinese and Western Medicine for Use in Myocardial Ischemia-Reperfusion Injury: A Review of Clinical Applications and Mechanisms

Myocardial ischemia-reperfusion injury (MIRI) is common in patients with acute coronary syndrome (ACS) after PCI treatment, which seriously affects the efficacy of revascularization and hinders the postoperative recovery of patients; therefore, the current study is focused on determining effective m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yuxuan, Li, Yan, Li, Bin, Liu, Yang, Zhang, Jingqian, Kuang, Wu, Lu, Jinjin, Cao, Zheng, Cui, Jie, Fan, Zongjing, Guo, Bin, Li, Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318772/ https://www.ncbi.nlm.nih.gov/pubmed/34335837 http://dx.doi.org/10.1155/2021/7409094

Ejemplares similares

Protective Effect and Mechanism of Traditional Chinese Medicine on Myocardial Ischemia Reperfusion Injury
por: Liu, Kuo, et al.
Publicado: (2022)

Research progress on effects of traditional Chinese medicine on myocardial ischemia–reperfusion injury: A review
por: Xing, Na, et al.
Publicado: (2022)

Traditional Chinese Medicine Shuang Shen Ning Xin Attenuates Myocardial Ischemia/Reperfusion Injury by Preserving of Mitochondrial Function
por: Li, Xueli, et al.
Publicado: (2014)

Ischemia-Reperfusion Injury in Peripheral Artery Disease and Traditional Chinese Medicine Treatment
por: Liang, Zenghui, et al.
Publicado: (2021)

Effects and Mechanisms of Chinese Herbal Medicine in Ameliorating Myocardial Ischemia-Reperfusion Injury
por: Liu, Qing, et al.
Publicado: (2013)

Traditional Chinese Medicine for Acute Myocardial Infarction in Western Medicine Hospitals in China
por: Spatz, Erica S., et al.
Publicado: (2018)

The Protective Effect of Traditional Chinese Medicine on Liver Ischemia-Reperfusion Injury
por: Ma, Wen, et al.
Publicado: (2021)

Protective Effects of Shen-Yuan-Dan, a Traditional Chinese Medicine, against Myocardial Ischemia/Reperfusion Injury In Vivo and In Vitro
por: Liu, Hongxu, et al.
Publicado: (2013)

Renal-Protective Effects and Potential Mechanisms of Traditional Chinese Medicine after Ischemia-Reperfusion Injury
por: Liu, Demin, et al.
Publicado: (2021)

Research Trends, Hot Spots, and Prospects for Traditional Chinese Medicine in the Field of Ischemia-Reperfusion Injury
por: Sun, Yu, et al.
Publicado: (2021)

The Role of PKC and HIF-1 and the Effect of Traditional Chinese Medicinal Compounds on Cerebral Ischemia-Reperfusion Injury
por: Fang, Zheyu, et al.
Publicado: (2022)

Acute and long-term cardioprotective effects of the Traditional Chinese Medicine MLC901 against myocardial ischemia-reperfusion injury in mice
por: Vincent, Anne, et al.
Publicado: (2017)

Protective effect of morin on myocardial ischemia-reperfusion injury in rats
por: Liu, Shuang, et al.
Publicado: (2018)

Chinese Herbal Medicine Alleviates Myocardial Ischemia/Reperfusion Injury by Regulating Endoplasmic Reticulum Stress
por: Liang, Wu-Lin, et al.
Publicado: (2021)

Treatment with placental growth factor attenuates myocardial ischemia/reperfusion injury
por: Zhang, Yabing, et al.
Publicado: (2018)

Rhynchophylline ameliorates myocardial ischemia/reperfusion injury through the modulation of mitochondrial mechanisms to mediate myocardial apoptosis
por: Qin, Qiao-Ji, et al.
Publicado: (2019)

Comparative Study of Traditional Chinese Medicine and Western Medicine in the Treatment of Coronavirus
por: Shen, Li, et al.
Publicado: (2020)

Role of traditional Chinese medicine monomers in cerebral ischemia/reperfusion injury:a review of the mechanism
por: Zheng, Ting, et al.
Publicado: (2023)

A Systematic Review and Meta-Analysis of Phytoestrogen Protects Against Myocardial Ischemia/Reperfusion Injury: Pre-Clinical Evidence From Small Animal Studies
por: Wang, Yumeng, et al.
Publicado: (2022)

Combined Therapy with Traditional Chinese Medicine and Antiplatelet Drugs for Ischemic Heart Disease: Mechanism, Efficacy, and Safety
por: Yu, Zongliang, et al.
Publicado: (2021)

Combination of Traditional Chinese and Western Medicine in Sports in Pharmaceutical Health
por: Zhangyanhui,, et al.
Publicado: (2021)

Study on the clinical assessment of integrated rehabilitation of Traditional Chinese Medicine and western medication for acute myocardial infarction
por: Zhao, Zhiqiang, et al.
Publicado: (2020)

Study on the Effect of Antiplatelet and Gastric Mucosal Protection of Traditional Chinese Medicine Invigorating Qi and Hemostasis
por: Zhang, Chen-Hao, et al.
Publicado: (2021)

Therapeutic targets by traditional Chinese medicine for ischemia-reperfusion injury induced apoptosis on cardiovascular and cerebrovascular diseases
por: Cheng, Xiuli, et al.
Publicado: (2022)

Advances in research on the protective mechanisms of traditional Chinese medicine (TCM) in myocardial ischaemia-reperfusion injury
por: Zhang, Jiexin, et al.
Publicado: (2022)

Survival Benefits of Western and Traditional Chinese Medicine Treatment for Patients With Pancreatic Cancer
por: Yang, Xue, et al.
Publicado: (2015)

Shuangshen Ningxin Capsule, a Traditional Chinese Medicinal Preparation, Alleviates Myocardial Ischemia through Autophagy Regulation
por: Wang, Jun, et al.
Publicado: (2015)

Pre-clinical Evidence: Berberine as a Promising Cardioprotective Candidate for Myocardial Ischemia/Reperfusion Injury, a Systematic Review, and Meta-Analysis
por: Chen, Cong, et al.
Publicado: (2021)

Long Noncoding RNAs in Myocardial Ischemia-Reperfusion Injury
por: Zhao, Zhuo, et al.
Publicado: (2021)

Visnagin ameliorates myocardial ischemia/reperfusion injury through the promotion of autophagy and the inhibition of apoptosis
por: Fu, Hai-rong, et al.
Publicado: (2010)

Potential application of traditional Chinese medicine in cerebral ischemia—Focusing on ferroptosis
por: Zhao, Fengyan, et al.
Publicado: (2022)

Intravenous Administration of Lycopene, a Tomato Extract, Protects against Myocardial Ischemia-Reperfusion Injury
por: Tong, Chao, et al.
Publicado: (2016)

Delivery of Hydrogen Sulfide by Ultrasound Targeted Microbubble Destruction Attenuates Myocardial Ischemia-reperfusion Injury
por: Chen, Gangbin, et al.
Publicado: (2016)

The Guizhi Gancao Decoction Attenuates Myocardial Ischemia-Reperfusion Injury by Suppressing Inflammation and Cardiomyocyte Apoptosis
por: Gao, Yuan, et al.
Publicado: (2019)

Nonalcoholic Fatty Liver Disease: Pathogenesis and Treatment in Traditional Chinese Medicine and Western Medicine
por: Shi, Tingting, et al.
Publicado: (2020)

Treatment of COVID-19 by monoclonal antibodies and the traditional Chinese medicine
por: Ling, Yuyan, et al.
Publicado: (2022)

A case report of effective treatment of diabetic foot with the integration of traditional Chinese medicine and western medicine
por: Gu, Jiaojiao, et al.
Publicado: (2022)

Protective effect of celastrol on myocardial ischemia–reperfusion injury
por: Li, Xiaoyan, et al.
Publicado: (2017)

Preclinical multi-target strategies for myocardial ischemia-reperfusion injury
por: Li, Yuqing, et al.
Publicado: (2022)

Pharmaceutical Therapies for Necroptosis in Myocardial Ischemia–Reperfusion Injury
por: Zhang, Yinchang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hut5si47qf3gall47ap6sfftc4